PB0776 Characterization of the Effects of Hydroxyurea and Crizanlizumab on Plasma Immunothrombosis Biomarkers in Patients with Sickle Cell Disease

Autor: Bochenek, V., Wu, J., Ngo, A., Levine, N., Kowalska, M., Abdulmalik, O., Risman, M., Weaver, J., Roe, A., Gollomp, K.
Zdroj: In Research and Practice in Thrombosis and Haemostasis October 2023 7 Supplement 2
Databáze: ScienceDirect
Externí odkaz: